BDX Q1 2024 Earnings — Becton, Dickinson and Company Revenue & Financial Results | Market Cap Arena

BDXBecton, Dickinson and Company

$60B

Q1 2024 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$4.7B+2.6% YoY

Gross Profit

$2.0B43.1% margin

Operating Income

$439M9.3% margin

Net Income

$281M6.0% margin

EPS (Diluted)

$0.96

QoQ Revenue Growth

-7.5%

Cash Flow

Operating Cash Flow

$841M

Free Cash Flow

$725M

Stock-Based Comp.

$83M

Balance Sheet

Total Assets

$52.3B

Total Liabilities

$26.9B

Stockholders' Equity

$25.3B

Cash & Equivalents

$1.2B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$4.7B	$4.6B	+2.6%
Gross Profit	$2.0B	$2.1B	-5.0%
Operating Income	$439M	$585M	-25.0%
Net Income	$281M	$509M	-44.8%

Revenue Segments

Medical

$2.2B47%

Life Sciences

$1.3B27%

Interventional

$1.2B25%

Geographic Segments

UNITED STATES

$2.7B58%

Non-US

$2.0B42%